Outcomes 2019 - Baylor Scott & White Heart and Vascular Hospital BSWHHVH_646_2019 Outcomes JOOMAG MOD | Page 73

Milton Packer, MD, Distinguished
Scholar in Cardiovascular Science,
is an internationally recognized
expert on cardiology and
specifically heart failure. He assists
in efforts on the Dallas campus
to focus research studies on the
development of drugs and devices to treat heart
failure and ultimately enhance patient care. Two
years ago, Dr. Packer started “Revolution and
Revelation” a weekly blog on MedPages Today’s
website. He currently enjoys a large following and
comments on his blog posts generally are in the
double digits. Designed as an attention-getter,
Dr. Packer says the blog gives him an opportunity
to share his thoughts on cardiovascular medicine
and healthcare in general that couldn’t be shared
in a medical journal. He’s also been sought after
for commentary by various media outlets during
fiscal year 2019.
Dr. Packer authored or co-authored many
important papers in FY19. Below are a few from
his extensive list:
• “Proportionate and Disproportionate
Functional Mitral Regurgitation: A New
Conceptual Framework That Reconciles the
Results of the MITRA-FR and COAPT Trials.
Grayburn PA, Sannino A, Packer M. JACC
Cardiovasc Imaging. 2019 Feb.;12(2):353-362.
Doi: 101016/j.jcmg.2018.11.006. Epub 2018 Dec
12. Review.
• “Effect of neprilysin inhibition on renal function
in patients with type 2 diabetes and chronic
heart failure who are receiving target doses
of inhibitors of the renin-angiotensin system: a
secondary analysis of the PARADIGM-HF trial.”
Packer M, Claggett B, Lefkowitz MP, McMurray
JJV, Rouleau JL, Solomon SD, Zile MR. Lancet
Diabetes Endocrinol, 2018 Jul;6(7):547-554.
Doi: 10.1016/S2213-8587(18)30100-1. Epub 2018
Apr 13.k.
mediates the effects of systemic inflammation
on the myocardium.” Packer M. J Am Coll
Cardiol 2018;71:2360-2372.
• “The leptin-aldosterone-neprilysin axis:
identification of its role in the pathogenesis
of the three phenotypes of heart failure
in obese people.” Packer M. Circulation
2018;137:1614-1631.
Dr. Packer also participated in and led sessions
at three highly acclaimed cardiovascular events
during fiscal year 2019:
• European Society of Cardiology,
Munich, Germany
• Global CardioVascular Clinical Trialists
(CVCT) Forum
• American College of Cardiology (ACC)
He was the speaker for the Paul Wood Lecture
at the British Cardiovascular Society 2019
Annual Conference. His presentation was titled,
“Identifying and treating the triggers of heart
failure: a crisis of evidence.” He was a discussant
and lecturer at TVT, The Structural Heart
Summit in Chicago. Also in fiscal year 2019, Dr.
Packer received an appointment at the Imperial
College in London at the Brompton where he is
a researcher, collaborator and attends several
meetings and teaching sessions per year.
For more information about the Cardiac
Imaging Core Laboratory at Baylor Scott &
White, call 214.818.1803.
• “Epicardial adipose tissue: the transducer that
Dr. Grayburn is an associate editor for the
Journal of the American College of Cardiology:
Cardiovascular Imaging and also an associate
editor for American Journal of Cardiology and
Structural Heart: Journal of the Heart Team.
73